Evidence map›Paper›PMID 27716617›Full record

ArticleOncotarget2016

Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions.

Anna-Katharina Wernicke, Yuri Churin, Diana Sheridan, Anita Windhorst, Annette Tschuschner, Stefan Gattenlöhner, Martin Roderfeld, Elke Roeb

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Extracellular Matrix Biomarkers in Colorectal Cancer.International journal of molecular sciences · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Anna-Katharina WernickeDepartment of Gastroenterology, Justus-Liebig-University, Giessen, Germany.
Yuri ChurinDepartment of Gastroenterology, Justus-Liebig-University, Giessen, Germany.
Diana SheridanDepartment of Pathology, Justus-Liebig-University, Giessen, Germany.
Anita WindhorstInstitute for Medical Informatics, Justus-Liebig-University, Giessen, Germany.
Annette TschuschnerDepartment of Gastroenterology, Justus-Liebig-University, Giessen, Germany.
Stefan GattenlöhnerDepartment of Pathology, Justus-Liebig-University, Giessen, Germany.
Martin RoderfeldDepartment of Gastroenterology, Justus-Liebig-University, Giessen, Germany.
Elke RoebDepartment of Gastroenterology, Justus-Liebig-University, Giessen, Germany.
University of Giessen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An exact classification of precancerous stages of colorectal polyps might improve therapy and patients´ outcome. Here we investigate the association between grade of dysplasia and Matrix metalloproteinase-13 (MMP-13) expression in 137 biopsies from patients with cancerous and non-cancerous colorectal adenomas. A reproducible staining procedure for histologic MMP-13 analysis in routinely fixed colorectal biopsy specimens has been established. A newly adopted immunoreactive scoring system for MMP-13 was demonstrated as reliable readout.The strength of the association between pathologic stage and immunoreactive MMP-13 scoring emphasizes its eligibility for diagnosis in precancerous colorectal lesions.

Indexed as

AgedAged, 80 and overBiomarkersBiopsyColorectal NeoplasmsFemaleHumansImmunohistochemistryMaleMatrix Metalloproteinase 13Middle AgedNeoplasm GradingNeoplasm StagingPrecancerous ConditionsBiomarkersMatrix Metalloproteinase 13adenomacolon cancerimmunoreactive scoringMMPneoplasia

Identifiers

PMID27716617
PMCPMC5341998
OpenAlexW2528476707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.